Caxton Associates (New York)’s Inovalon Holdings, Inc. Class A Common Stock INOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-17,472
Closed -$462K 367
2020
Q3
$462K Sell
17,472
-15,274
-47% -$358K 0.05% 125
2020
Q2
$631K Buy
32,746
+20,420
+166% +$362K 0.06% 104
2020
Q1
$205K Hold
12,326
0.04% 345
2019
Q4
$232K Sell
12,326
-3,136
-20% -$52.5K 0.03% 331
2019
Q3
$253K Buy
+15,462
New +$247K 0.05% 296

Other funds holding INOV

Caxton Associates (New York)'s INOV Position: Q4 2020 in Review

Caxton Associates (New York) sold out of Inovalon Holdings, Inc. Class A Common Stock (INOV) in Q4 2020, closing a stake of 17,472 shares — an estimated $462K sold.

Caxton Associates (New York) first reported a position in INOV in Q3 2019 and held it in 5 quarters. The position peaked at $631K in Q2 2020. 174 funds tracked by Wall St. Rank hold INOV as of Q4 2020.

  • Caxton Associates (New York) reported no remaining Inovalon Holdings, Inc. Class A Common Stock position as of Q4 2020 after selling out during the quarter.
  • Caxton Associates (New York) sold 17,472 Inovalon Holdings, Inc. Class A Common Stock shares in Q4 2020, an estimated $462K.
  • Caxton Associates (New York) first reported a position in Inovalon Holdings, Inc. Class A Common Stock in Q3 2019 and held it in 5 quarters.
  • Caxton Associates (New York)'s Inovalon Holdings, Inc. Class A Common Stock position peaked at $631K in Q2 2020.
  • 174 funds tracked by Wall St. Rank held Inovalon Holdings, Inc. Class A Common Stock as of Q4 2020.

Based on Caxton Associates (New York)'s 13F filing for Q4 2020, filed 16 Feb 2021.